Force characteristics of in vivo tissue-engineered myocardial constructs using varying cell seeding densities

被引:9
|
作者
Birla, Ravi [1 ]
Dhawan, Vikas [2 ]
Huang, Yen-Chih [1 ]
Lytle, Ian [2 ]
Tiranathanagul, Khajohn [3 ]
Brown, David [2 ]
机构
[1] Univ Michigan, Sect Cardiac Surg, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sect Plast Surg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sect Internal Med, Ann Arbor, MI 48109 USA
关键词
cardiac myocytes; active force; cell seeding density; implantation; angiogenesis; tissue engineering;
D O I
10.1111/j.1525-1594.2008.00591.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Experiments have been successfully performed culminating in functional, vascularized, three-dimensional cardiac muscle tissue. Past experience in tissue engineering has led us to the understanding that cell seeding density plays a critical role in the formation and function of both in vitro and in vivo engineered tissues. Therefore, to improve upon the mechanics of this model and to facilitate the formation of myocardial tissue with improved functional performance, we sought to optimize the seeding density of cardiomyocytes in these constructs. Neonatal cardiac myocytes were isolated from 2-day-old Fischer 344 rat hearts. Silicone chambers containing fibrin gel were seeded with varying numbers of cardiac cells (1, 5, 10, and 20 million). Control chambers were prepared using fibrin gel alone. All of the chambers were then implanted around the femoral vessels of isogenic rats. Six constructs per cell seeding density group were implanted. Histological and immunohistochemical evaluation was performed via hematoxylin and eosin, von Gieson, and alpha-sarcomeric actin staining protocols. Linear contractile force measurements were obtained for each construct following 4 weeks of in vivo implantation. After an implantation period of 4 weeks, the newly formed cardiac constructs contained within the chambers were harvested. The femoral vessels within the constructs were found to be patent in all cases. With direct electrical stimulation, the constructs were able to generate an average active force that varied depending on their seeding density. Constructs with seeding densities of 1, 5, 10, and 20 million cells produced an average active force of 208, 241, 151, and 108 mu N, respectively. The control constructs did not generate any active force on electrical stimulation. This study demonstrates the in vivo survival, vascularization, organization, and function of transplanted myocardial cells. It is also apparent that cell seeding density plays a direct role in the force generation and mechanical properties of these engineered constructs. Among different groups using varying cell seeding densities, we found that the group with 5 million cells generated maximum active force.
引用
收藏
页码:684 / 691
页数:8
相关论文
共 50 条
  • [1] Fabrication and In Vivo Microanastomosis of Vascularized Tissue-Engineered Constructs
    Hooper, Rachel Campbell
    Hernandez, Karina A.
    Boyko, Tatiana
    Harper, Alice
    Joyce, Jeremiah
    Golas, Alyssa R.
    Spector, Jason A.
    TISSUE ENGINEERING PART A, 2014, 20 (19-20) : 2711 - 2719
  • [2] Cryopreservation of Cell/Scaffold Tissue-Engineered Constructs
    Costa, Pedro F.
    Dias, Ana F.
    Reis, Rui L.
    Gomes, Manuela E.
    TISSUE ENGINEERING PART C-METHODS, 2012, 18 (11) : 852 - 858
  • [3] An Overview of Methods for the In Vivo Evaluation of Tissue-Engineered Skin Constructs
    Lammers, Gerwen
    Verhaegen, Pauline D. H. M.
    Ulrich, Magda M. W.
    Schalkwijk, Joost
    Middelkoop, Esther
    Weiland, Daniela
    Nillesen, Suzan T. M.
    Van Kuppevelt, Toin H.
    Daamen, Willeke F.
    TISSUE ENGINEERING PART B-REVIEWS, 2011, 17 (01) : 33 - 55
  • [4] Effect of seeding technique and scaffold material on bone formation in tissue-engineered constructs
    Schliephake, H.
    Zghoul, N.
    Jaeger, V.
    van Griensven, M.
    Zeichen, J.
    Gelinsky, M.
    Wuelfing, T.
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009, 90A (02) : 429 - 437
  • [5] Tissue-engineered skin substitutes:: from in vitro constructs to in vivo applications
    Auger, FA
    Berthod, F
    Moulin, W
    Pouliot, R
    Germain, L
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2004, 39 : 263 - 275
  • [6] Decelerated vascularization in tissue-engineered constructs in association with diabetes mellitus in vivo
    Schumann, Paul
    Lindhorst, Daniel
    Kampmann, Andreas
    Gellrich, Nils-Claudius
    Krone-Wolf, Sonja
    Meyer-Lindenberg, Andrea
    von See, Constantin
    Gander, Thomas
    Lanzer, Martin
    Rucker, Martin
    Essig, Harald
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (07) : 855 - 864
  • [7] Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force
    Ito, A
    Ino, K
    Hayashida, M
    Kobayashi, T
    Matsunuma, H
    Kagami, H
    Ueda, M
    Honda, H
    TISSUE ENGINEERING, 2005, 11 (9-10): : 1553 - 1561
  • [8] Tissue-engineered vascular grafts: does cell seeding matter?
    Mirensky, Tamar L.
    Hibino, Narutoshi
    Sawh-Martinez, Rajendra F.
    Yi, Tai
    Villalona, Gustavo
    Shinoka, Toshiharu
    Breuer, Christopher K.
    JOURNAL OF PEDIATRIC SURGERY, 2010, 45 (06) : 1299 - 1305
  • [9] Renal therapy using tissue-engineered constructs and gene delivery
    Gilad E. Amiel
    James J. Yoo
    Anthony Atala
    World Journal of Urology, 2000, 18 : 71 - 79
  • [10] Renal therapy using tissue-engineered constructs and gene delivery
    Amiel, GE
    Yoo, JJ
    Atala, A
    WORLD JOURNAL OF UROLOGY, 2000, 18 (01) : 71 - 79